MYP_169394
Basic Information
SL-ENF(Sialic acid Enfuvirtide)
Antiviral
Antiviral Antiviral mechanism Viral fusion inhibition Fusion inhibitor
Standard
37 amino acids
C205H303N51O65S
Standard
Sequence
CYTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF
Physicochemical Analysis
4553.97 Da
4.30
-5.15
-5.43
-0.1391
-0.78
0.46
-0.04
61.23
87.03
0.1351
17990.00
17990.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1923.12
-15.54
65.0
62.0
153.0
322.0
9.0
43.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0234386 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Sialic acid
Amidation
Bio-Activity Profile
Antiviral
Anti-viral potency
0.002 μM
EC50
Sprague-Dawey (SD) rats Plasma, in vivo; 83160 s
RECORD: Rec_0264339 VERIFIED: YES
Provenance & Taxonomy
not reported [other]
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Acetylation
None
Mal-PEG12-CP was conjugated to Cys-enfuvirtide
Bio-Activity Profile
Antiretroviral fusion inhibitor
0.051 μM
LC-MS/MS
Female Wistar rats, in vivo; 37440 s
RECORD: Rec_0273303 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Lactic acid
Amidation
Bio-Activity Profile
Antiviral
Anti-viral potency
0.002 μM
EC50
Sprague-Dawey (SD) rats Plasma, in vivo; 15120 s